Leo Grady, Paige, on transforming precision medicine through AI

Stay updated on releases: subscribe on the Spotify, Apple, Twitter, or Stitcher.

In this episode, we meet Leo Grady, CEO of Paige. Paige is a global leader in AI-based software in pathology with a mission to drive the future of precision medicine. Paige is committed to transforming the diagnostics space by building an industry-leading portfolio of AI-based clinical applications, biomarkers and diagnostics.

Paige recently closed a $125 million Series C round, co-led by Casdin Capital, Johnson & Johnson Innovation and KKR, bringing the company’s total funding to $220 million since its launch in 2018. Paige has been honored as one of Fierce Medtech’s 2020 Fierce 15 companies and a New York Healthcare Innovation: Digital Health 100 Company.

Prior to joining Paige, Leo was the Senior Vice President of Engineering at HeartFlow, a medical technology company transforming the way cardiovascular disease is diagnosed and treated. Leo spent his early career at Siemens as a Principal Research Scientist and Line Manager, focusing on applying AI in clinical applications such as in vitro diagnostics. He holds a Ph.D. in Cognitive and Neural Systems from Boston University and a bachelor’s from the University of Vermont.

Leo Grady, CEO of Paige

In this episode, Leo and I chat about:

  • The founding story of Paige and collaboration with Memorial Sloan Kettering Cancer Center

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Digital Health Forward

Sharing the stories of healthcare leaders, entrepreneurs and executives who are moving the digital health industry forward.